NCT03659201View on ClinicalTrials.gov

Efficacy and Safety of Neosil on Chronic Effluvium

PHASE4CompletedINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

September 3, 2018

Primary Completion Date

June 4, 2019

Study Completion Date

March 30, 2020

Conditions
Chronic Telogen Effluvium
Interventions
DRUG

Neosil complete

Oral, during 24 weeks.

DRUG

Pantogar

Oral, placebo for 12 weeks and pantogar for 12 weeks.

DRUG

Neosil

Oral, during only 12 weeks.

Trial Locations (1)

13083190

Caep Centro Avancado de Estudos E Pesquisas Ltda, Campinas

Sponsors

Lead Sponsor

EMS

Collaborators (1)

Luxbiotech
All Listed Sponsors
collaborator

Luxbiotech

UNKNOWN

lead

EMS

INDUSTRY